Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Investigational New Drugs|January 1, 1983
Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group studyJ C Arseneau, B Bundy, H Homesley, et al.
Investigational New Drugs|January 1, 1986
A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanomaJ C Arseneau, D A Schoenfeld, E C Borden
Cancer|September 15, 1980
Cavitation of pulmonary metastases as a response to chemotherapyA R Thalinger, S N Rosenthal, S Borg, et al.
Investigational New Drugs|January 1, 1983
A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanomaJ C Arseneau, J M Wolter, M Kuperminc, et al.
American Journal of Clinical Oncology|August 1, 1982
Phase II study of m-AMSA in advances malignant melanomaJ C Arseneau, J M Wolter, J C Probert, et al.
American Journal of Clinical Oncology|February 1, 1982
Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervixJ C Arseneau, B Bundy, T Dolan, et al.
American Journal of Clinical Oncology|June 1, 1984
Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary. A Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, J C Arseneau, et al.
Cancer|May 15, 1980
Hepatic veno-occlusive disease due to DTICR F Asbury, S N Rosenthal, M E Descalzi, et al.
Lancet (London, England)|April 26, 1975
Second malignancies complicating Hodgkin's disease in remissionG P Canellos, J C Arseneau, V T DeVita, et al.
Breast Cancer Research and Treatment|January 1, 1981
A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancerD C Tormey, R Gelman, P R Band, et al.
Pageof 2